MAPS Europe B.V.: Clinical Trials

1 trial sponsored by MAPS Europe B.V., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow MAPS Europe B.V.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open Label Study of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-Study
Midomafetamine HCl - PTSD
Phase 2CompletedMAPS Europe B.V.212020-06-242025-01-28

Conditions studied

Stress Disorders, Post-Traumatic (1)

Interventions

N-Methyl-3,4-methylenedioxyamphetamine (1)

Countries

Czechia (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Norway (1)  ·  United Kingdom (1)

Top investigators

Prof. Dr. Eric Vermetten, MD (1)